Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.

Nonomura Y, Nagasaka K, Hagiyama H, Sekine C, Nanki T, Tamamori-Adachi M, Miyasaka N, Kohsaka H.

Arthritis Rheum. 2006 Jul;54(7):2074-83.

2.

Retinoblastoma suppression of matrix metalloproteinase 1, but not interleukin-6, through a p38-dependent pathway in rheumatoid arthritis synovial fibroblasts.

Bradley K, Scatizzi JC, Fiore S, Shamiyeh E, Koch AE, Firestein GS, Gorges LL, Kuntsman K, Pope RM, Moore TL, Han J, Perlman H.

Arthritis Rheum. 2004 Jan;50(1):78-87.

3.

IL-6 and matrix metalloproteinase-1 are regulated by the cyclin-dependent kinase inhibitor p21 in synovial fibroblasts.

Perlman H, Bradley K, Liu H, Cole S, Shamiyeh E, Smith RC, Walsh K, Fiore S, Koch AE, Firestein GS, Haines GK 3rd, Pope RM.

J Immunol. 2003 Jan 15;170(2):838-45.

4.

Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.

Amin MA, Mansfield PJ, Pakozdi A, Campbell PL, Ahmed S, Martinez RJ, Koch AE.

Arthritis Rheum. 2007 Jun;56(6):1787-97.

5.

Gene transfer of a cell cycle modulator exerts anti-inflammatory effects in the treatment of arthritis.

Nonomura Y, Kohsaka H, Nagasaka K, Miyasaka N.

J Immunol. 2003 Nov 1;171(9):4913-9.

7.

Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.

Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, Doi H, Yoshida A, Yamana J, Yamamura M, Ninomiya Y, Inoue H, Asahara H.

Arthritis Rheum. 2004 Oct;50(10):3365-76.

8.

Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.

Ospelt C, Brentano F, Jüngel A, Rengel Y, Kolling C, Michel BA, Gay RE, Gay S.

Arthritis Rheum. 2009 Feb;60(2):355-63. doi: 10.1002/art.24226.

9.

Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.

Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J.

J Biol Chem. 2000 Jan 7;275(1):444-50.

11.

MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S.

Arthritis Rheum. 2009 May;60(5):1294-304. doi: 10.1002/art.24475.

12.

Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.

Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S.

Arthritis Rheum. 2003 Mar;48(3):642-50.

14.

Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.

Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.

Arthritis Res Ther. 2006;8(4):R132.

15.

Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.

Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN, Knowles DM, Lane J, Chen-Kiang S.

Cancer Res. 2005 Dec 15;65(24):11345-53.

16.

CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.

García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM, Díaz-González F.

Arthritis Rheum. 2004 Dec;50(12):3866-77.

17.
18.

Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints.

Nonomura Y, Kohsaka H, Nasu K, Terada Y, Ikeda M, Miyasaka N.

Int Immunol. 2001 Jun;13(6):723-31.

PMID:
11369699
19.

Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.

Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, Nojima Y.

Arthritis Rheum. 2005 Apr;52(4):1037-46.

20.

Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.

Hintzen C, Quaiser S, Pap T, Heinrich PC, Hermanns HM.

Arthritis Rheum. 2009 Jul;60(7):1932-43. doi: 10.1002/art.24602.

Supplemental Content

Support Center